Dolby Laboratories (NYSE:DLB) Issues FY25 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its FY25 earnings guidance on Tuesday. The company provided EPS guidance of $2.43-2.58 for the period, compared to the consensus EPS estimate of $2.77. The company issued revenue guidance of $1.33-1.39 billion, compared to the consensus revenue estimate of $1.33 billion. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Trading Down 2.0 %

DLB opened at $80.31 on Friday. The company’s fifty day moving average price is $74.15 and its two-hundred day moving average price is $76.08. The company has a market cap of $7.66 billion, a price-to-earnings ratio of 29.63 and a beta of 0.98. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $90.06.

Dolby Laboratories Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 10th. Shareholders of record on Tuesday, December 3rd will be paid a dividend of $0.33 per share. The ex-dividend date is Tuesday, December 3rd. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a yield of 1.64%. Dolby Laboratories’s dividend payout ratio (DPR) is 44.28%.

Dolby Laboratories announced that its board has approved a stock buyback plan on Wednesday, August 7th that permits the company to repurchase $350.00 million in shares. This repurchase authorization permits the electronics maker to reacquire up to 5% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

DLB has been the subject of several recent analyst reports. Rosenblatt Securities upped their target price on Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday. StockNews.com upgraded Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Monday. Finally, Barrington Research reissued an “outperform” rating and issued a $100.00 price objective on shares of Dolby Laboratories in a report on Wednesday.

Insider Buying and Selling at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 28,512 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the transaction, the chief executive officer now directly owns 83,721 shares of the company’s stock, valued at approximately $6,205,400.52. This trade represents a 25.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 39.54% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.